Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing the significance of severe coronary artery blockages before PCI

Official title: Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI (REFINE PCI)

Run by Beth Israel Deaconess Medical Center · NCT05491668 · Data updated 2026-11-12

This study is testing if a new way of measuring blood flow can help doctors better understand the impact of severe blockages in heart arteries before and after a procedure called PCI.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment107 (estimated)
SponsorBeth Israel Deaconess Medical Center
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 11, 2022
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedJune 11, 2026
Trial IDNCT05491668 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with stable coronary artery disease or acute coronary syndromes who are scheduled for cardiac catheterization and have at least one lesion visually estimated to be 70% or more blocked.

Probably not a fit

Patients with acute ST Elevation Myocardial Infarction (STEMI) or Non-ST Elevation Myocardial Infarction (NSTEMI) as the culprit vessel, or those with chronic total occlusions, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the physiological significance of coronary lesions that are visually assessed as severely blocked and are planned for percutaneous coronary intervention (PCI). It employs blinded physiological assessments both before and after the PCI procedure to determine the actual impact of these lesions on blood flow. The study aims to enhance the understanding of how invasive physiological testing can improve outcomes in patients undergoing PCI, particularly for lesions deemed severe by traditional angiographic methods. By utilizing advanced pressure-sensing technology, the study seeks to validate the effectiveness of non-hyperemic pressure ratio assessments in this context.

Why it matters

Potential benefit: If successful, this study could lead to improved patient outcomes by ensuring that only truly significant blockages are treated during PCI.

How similar studies have gone: Previous studies have shown success with physiology-guided PCI approaches, indicating that this study builds on established findings rather than exploring a completely novel concept.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>/= 18 years
* Patient provides written informed consent
* Clinical presentation with stable coronary artery disease or acute coronary syndromes (unstable angina, Non-ST Elevation Myocardial Infarction (NSTEMI), or ST Elevation Myocardial Infarction (STEMI))
* Scheduled for clinically indicated cardiac catheterization
* At least one lesion with angiographic severity visually estimated to be \>/= 70% diameter stenosis that is deemed suitable for PCI
* The operator plans to perform PCI on an ad hoc or planned basis
* The target lesion is not planned for assessment by invasive physiology

Exclusion Criteria:

* Failure to provide signed informed consent
* Culprit vessel of acute ST Elevation Myocardial Infarction (STEMI)
* Culprit vessel of Non-ST Elevation Myocardial Infarction (NSTEMI)
* Thrombolysis In Myocardial Infarction (TIMI) flow less than grade 3 at baseline or visible thrombus
* Chronic total occlusion (CTO) in the target vessel
* Target vessel is supplied by major collaterals or supplies major collaterals to a CTO
* Target lesion involves the left main coronary artery
* Prior history of coronary artery bypass grafting (CABG) to the target vessel, except if bypass graft is occluded
* Previously known untreated severe valvular heart disease
* Previously known left ventricular ejection fraction \<30%
* Sustained ventricular arrhythmias
* Patients who are currently pregnant (pregnancy testing will be performed as per standard cardiac catheterization laboratory protocol)

Where it's running

  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.